Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 11, Number 6—June 2005

Dispatch

Rifampicin Resistance in Tuberculosis Outbreak, London, England

Claire Jenkins*Comments to Author , Alleyna P. Claxton†, Robert J. Shorten*, Timothy D. McHugh*, and Stephen H. Gillespie*
Author affiliations: *Royal Free Hospital, London, United Kingdom; †Homerton Hospital, London, United Kingdom

Main Article

Figure 2

Suggested epidemiologic relationship between 6 cases of multidrug-resistant tuberculosis (MDR-TB). Resistance to rifampicin developed in patients 018, 483, and 915 while on therapy, whereas patients T7, 604, and 317 contracted primary MDR-TB. The type of mutation present in each patient's strain of MDR-TB is highlighted in bold.

Figure 2. . Suggested epidemiologic relationship between 6 cases of multidrug-resistant tuberculosis (MDR-TB). Resistance to rifampicin developed in patients 018, 483, and 915 while on therapy, whereas patients T7, 604, and 317 contracted primary MDR-TB. The type of mutation present in each patient's strain of MDR-TB is highlighted in bold.

Main Article

TOP